July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The average turn-around time of lab-based test results is 2.8 hours, with the minimum time to detect a heart attack using today’s lab-based immunodiagnostics is 4.5 hours from symptom outset.

July 23, 2010 - At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus (HIV), two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease (CVD) risk in people with HIV with significant implications for improving medica

July 23, 2010 – A new research and development center for medical imaging systems recently opened at University Hospitals Case Medical Center in northeastern Ohio. The Global Advanced Imaging Innovation Center brings together radiologic experts to coordinate clinical research, education, development and commercialization of advanced imaging technologies.

July 22, 2010 – Changes included in the final rules governing the meaningful use objectives for Medicare and Medicaid incentive programs for electronic health records (EHRs) will improve the odds that more providers can qualify for government stimulus funding.

July 22, 2010 – Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of platelet function testing.

July 22, 2010 — Western Maryland Regional Medical Center’s recent upgrade to the newest version of the Impax HeartStation ECG (electrocardiogram) Management System has helped enable the rapid diagnosis and treatment of patients with posterior wall heart attacks.

Laser sheaths used for EP device lead extraction.
Spectranetics laser sheath being used for EP device lead extraction.

Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently been the topic of numerous medical and nonmedical publications.

July 21, 2010 – The Advancing Patient Safety Coalition sent a letter to the U.S. Food and Drug Administration earlier this month, urging the agency to immediately issue rules on unique device identification (UDI), which have been three years in the making.


In addition to the FDA-cleared Gore Helex and the AGA Amplatzer transcatheter devices for atrial septal defects (ASDs), there are several others in development or already cleared for use outside the United States.

July 20, 2010 – The final results of the landmark TRUST Trial (Lumax-T/Lumos-T Safely RedUceS RouTine Office Device Follow-up), which show wireless remote monitoring of implantable cardiac devices offers earlier detection of potenial cardiac problems, were published in the July 27 issue of Circulation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now